Severe intra-abdominal bleeding post liver biopsy – failure to respond to recombinant Factor VII

• References

• 1 Hoffman R, Mahajana A, Agmon P. et al. Successful use of recombinant activated factor VII (Novoseven®) in controlling severe intra-abdominal bleeding after liver needle biopsy. Thromb Haemost 2002; 87: 346-7.
• 2 White B, McHale J, Ravi N. etal Successfuluse of recombinant factor VIIa in the management of intractable post surgical intra-abdominal haemorrhage. Br J Haematol 1999; 107 (03) 677-8.
• 3 Moscardo F, Perez F, de la Rubia J. et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intra-vascular coagulation using recombinant factor VII. Br J Haematol 2001; 114 (01) 174-6.
• 4 Friederich PW, Henny CP, Messelink EJ. et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled trial. Lancet 2003; 361 (9353): 201-5.
• 5 Jeffers L, Chalasani N, Balart L. et al. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparas-copic liver biopsy. Gastroenterol 2002; 123 (01) 118-26.
• 6 Bernstein DE, Jeffers L, Erhardtsen E. et al. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study. Gastroenterol 1997; 113 (06) 1930-7.
• 7 Lisman T, Leebeek FW, Meijer K. et al. Recombinant factor VIIa improves clot formation but not fibrinolytic potential in patients with cirrhosis and diuring liver transplantation. Hepatol 2002; 35 (03) 616-21.